Accelerated step-up dosing of glofitamab in rapidly progressive R/R DLBCL: a real-world cohort analysis
Blood Immunology & Cellular Therapy
· Elsevier
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Читать у издателя →
Цитирование
Accelerated step-up dosing of glofitamab in rapidly progressive R/R DLBCL: a real-world cohort analysis. // Blood Immunology & Cellular Therapy. – URL: https://www.sciencedirect.com/science/article/pii/S305059762600028X?dgcid=rss_sd_all
Accelerated step-up dosing of glofitamab in rapidly progressive R/R DLBCL: a real-world cohort analysis. Blood Immunology & Cellular Therapy. https://www.sciencedirect.com/science/article/pii/S305059762600028X?dgcid=rss_sd_all
“Accelerated step-up dosing of glofitamab in rapidly progressive R/R DLBCL: a real-world cohort analysis.” Blood Immunology & Cellular Therapy.
@article{article38461,
title = {Accelerated step-up dosing of glofitamab in rapidly progressive R/R DLBCL: a real-world cohort analysis},
journal = {Blood Immunology \& Cellular Therapy},
url = {https://www.sciencedirect.com/science/article/pii/S305059762600028X?dgcid=rss_sd_all}
}